RxDoctor Payments Data

Nathan Buck, MD

Anesthesiology · Murray, UTNPI 1487808242

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Chiesi USA, Inc. at 31.2% of the total. Reporting peaked in 2021 at $211 and has fallen 77.6% since, to $47 in 2025. Among anesthesiology clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$889in general payments, 2019–2025

Across 38 payments — averaging $23.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Chiesi USA, Inc.$277
  • Stryker$148
  • Merck$144
  • Abiomed$120
  • Acacia Pharma Inc$72
  • Edwards Lifesciences$39
  • plus $89 from 4 others

What the payments were for

  • Food & beverage$889100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Chiesi USA, Inc.16$277
Stryker1$148
Merck8$144
Abiomed1$120
Acacia Pharma Inc7$72
Edwards Lifesciences1$39
Octapharma USA, Inc.1$31
Zimmer Biomet1$22
Pajunk Medical Systems, LP1$18
Portola Pharmaceuticals, LLC1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$889 in reported general payments places this provider in the 90th percentile of 510 anesthesiology providers in Utah.

See all anesthesiology providers in Utah

Medicare billing

Part B allowed, 2024
$48,481
Medicare patients
119
Services billed
189

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Murray

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →